T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Dover
DOV
$27.8B
| $72.8M | 0.02% |
1,284,554
-320,622
| -20% | -$19.1M |
|
702
CF Industries
CF
$17.7B
| $72.8M | 0.02% |
1,132,580
+10,090
| +0.9% | +$614K |
|
|
RWT
703
Redwood Trust
RWT
$599M
| $72.5M | 0.01% |
4,620,745
+95,380
| +2% | +$1.62M |
|
|
WMGI
704
DELISTED
Wright Medical Group Inc
WMGI
| $71.9M | 0.01% |
2,736,925
+359,791
| +15% | +$9.51M |
|
705
Abercrombie & Fitch
ANF
$4.84B
| $71.8M | 0.01% |
3,339,000
+1,078,600
| +48% | +$23.7M |
|
|
CNL
706
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $71.4M | 0.01% |
1,325,220
-191,700
| -13% | -$10.4M |
|
|
CBF
707
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $71.2M | 0.01% |
2,450,620
-27,200
| -1% | -$775K |
|
708
Credicorp
BAP
$29.8B
| $71.2M | 0.01% |
512,659
-8,680
| -2% | -$1.27M |
|
709
Prudential Financial
PRU
$43B
| $71.2M | 0.01% |
813,590
-153,720
| -16% | -$13M |
|
710
Southern Company
SO
$107B
| $71.1M | 0.01% |
1,697,322
+93,170
| +6% | +$4.06M |
|
|
ZSPH
711
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $71M | 0.01% |
1,354,558
-6,020
| -0.4% | -$296K |
|
|
ALEX
712
DELISTED
Alexander & Baldwin
ALEX
| $70.7M | 0.01% |
1,795,165
+29,083
| +2% | +$1.2M |
|
|
ECOL
713
DELISTED
US Ecology, Inc.
ECOL
| $70.5M | 0.01% |
1,447,580
-452,416
| -24% | -$21.8M |
|
|
XXIA
714
DELISTED
Ixia
XXIA
| $70.4M | 0.01% |
5,662,660
-47,730
| -0.8% | -$595K |
|
715
Kroger
KR
$35.1B
| $70.3M | 0.01% |
1,939,688
-1,126,042
| -37% | -$40.9M |
|
|
STFC
716
DELISTED
State Auto Financial Corp
STFC
| $70.3M | 0.01% |
2,933,625
+189,986
| +7% | +$4.4M |
|
|
TESO
717
DELISTED
Tesco Corp
TESO
| $70.2M | 0.01% |
6,444,580
-35,120
| -0.5% | -$422K |
|
|
GG
718
DELISTED
Goldcorp Inc
GG
| $70.2M | 0.01% |
4,335,967
+950,299
| +28% | +$17.3M |
|
719
Etsy
ETSY
$7.4B
| $70.2M | 0.01% |
+4,997,920
| New | +$96.1M |
|
720
Williams Companies
WMB
$89.3B
| $70.2M | 0.01% |
1,222,583
+43,650
| +4% | +$2.25M |
|
721
Kimberly-Clark
KMB
$36.8B
| $69.7M | 0.01% |
657,415
+20,500
| +3% | +$2.23M |
|
722
Dorman Products
DORM
$3.95B
| $69.4M | 0.01% |
1,456,410
+10,950
| +0.8% | +$534K |
|
723
Jazz Pharmaceuticals
JAZZ
$16B
| $69.3M | 0.01% |
393,800
+100
| +0% | +$18K |
|
724
Chord Energy
CHRD
$7.35B
| $69.3M | 0.01% |
4,373,926
-2,345,410
| -35% | -$39.5M |
|
725
Sempra
SRE
$56.5B
| $69.2M | 0.01% |
1,398,930
-110,724
| -7% | -$5.86M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.